| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2003;34:2970.)
© 2003 American Heart Association, Inc.
Original Contributions |
From the Departments of Internal Medicine (C.A.G., D.D.H., F.M.F.) and Pharmacology (D.D.H., F.M.F.), University of Iowa Carver College of Medicine and Veterans Affairs Medical Center, Iowa City.
Correspondence to Carol A. Gunnett, PhD, Department of Internal Medicine, University of Iowa College of Medicine, Iowa City, IA 52242-1081. E-mail Carol-Gunnett{at}uiowa.edu
Background and Purpose Inducible nitric oxide synthase (iNOS) is a mediator of vascular dysfunction during inflammation. The purpose of this study was to test the hypothesis that vascular dysfunction during diabetes is dependent on expression of iNOS.
Methods Diabetes was produced in mice with streptozotocin (150 mg/kg IP). After 4 to 6 months of diabetes, vasomotor function was examined in vitro in carotid arteries from mice with targeted disruption of the gene for iNOS (iNOS-deficient mice) and from normal, wild-type (WT) mice.
Results Contractile responses of carotid arteries to U46619, a thromboxane A2 analogue, were not altered by diabetes in WT mice. Responses to U46619 were increased in arteries from diabetic iNOS-deficient mice compared with diabetic WT and nondiabetic mice (iNOS-deficient and WT mice). These results indicate that expression of iNOS inhibits an increased vasoconstrictor response during diabetes. Arteries from nondiabetic WT mice relaxed 83±2% (mean±SE) in response to acetylcholine (1 µmol/L) compared with 58±6% in arteries from diabetic WT mice (P<0.05 versus nondiabetic mice). In contrast, relaxation of carotid arteries to acetylcholine was similar (81±4% versus 76±6%; P>0.05) in iNOS-deficient mice under nondiabetic and diabetic conditions, respectively. Thus, diabetes produced impairment of endothelium-dependent relaxation in arteries from WT but not iNOS-deficient mice. Endothelium-independent relaxation in response to nitroprusside was similar in arteries from all mice.
Conclusions These results provide the first direct evidence that impairment of endothelium-dependent relaxation during diabetes is dependent on expression of iNOS.
Key Words: acetylcholine endothelium-derived relaxing factor nitric oxide streptozotocin
This article has been cited by other articles:
![]() |
L. Tie, X.-J. Li, X. Wang, K. M. Channon, and A. F. Chen Endothelium-specific GTP cyclohydrolase I overexpression accelerates refractory wound healing by suppressing oxidative stress in diabetes Am J Physiol Endocrinol Metab, June 1, 2009; 296(6): E1423 - E1429. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kitayama, F. M. Faraci, C. A. Gunnett, and D. D. Heistad Impairment of Dilator Responses of Cerebral Arterioles During Diabetes Mellitus: Role of Inducible NO Synthase Stroke, August 1, 2006; 37(8): 2129 - 2133. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Barr The Practitioner's Dilemma: Can We Use a Patient's Race To Predict Genetics, Ancestry, and the Expected Outcomes of Treatment? Ann Intern Med, December 6, 2005; 143(11): 809 - 815. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Nagareddy, Z. Xia, J. H. McNeill, and K. M. MacLeod Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2144 - H2152. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Gunnett, D. D. Lund, F. M. Faraci, and D. D. Heistad Vascular interleukin-10 protects against LPS-induced vasomotor dysfunction Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H624 - H630. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.A. Gunnett, D.D. Lund, A.K. McDowell, F.M. Faraci, and D.D. Heistad Mechanisms of Inducible Nitric Oxide Synthase-Mediated Vascular Dysfunction Arterioscler Thromb Vasc Biol, August 1, 2005; 25(8): 1617 - 1622. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Noronha, J.-M. Li, S. B. Wheatcroft, A. M. Shah, and M. T. Kearney Inducible Nitric Oxide Synthase Has Divergent Effects on Vascular and Metabolic Function in Obesity Diabetes, April 1, 2005; 54(4): 1082 - 1089. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yasukawa, E. Tokunaga, H. Ota, H. Sugita, J. A. J. Martyn, and M. Kaneki S-Nitrosylation-dependent Inactivation of Akt/Protein Kinase B in Insulin Resistance J. Biol. Chem., March 4, 2005; 280(9): 7511 - 7518. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Faraci Oxidative Stress: The Curse That Underlies Cerebral Vascular Dysfunction? Stroke, February 1, 2005; 36(2): 186 - 188. [Full Text] [PDF] |
||||
![]() |
H. Li, D. D. Gutterman, N. J. Rusch, A. Bubolz, and Y. Liu Nitration and Functional Loss of Voltage-Gated K+ Channels in Rat Coronary Microvessels Exposed to High Glucose Diabetes, September 1, 2004; 53(9): 2436 - 2442. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Faraci and S. P. Didion Vascular Protection: Superoxide Dismutase Isoforms in the Vessel Wall Arterioscler Thromb Vasc Biol, August 1, 2004; 24(8): 1367 - 1373. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |